Wei, X., Xing, X., Yao, W., Wang, C., Xiao, Y., & Du, X. (2025). First-line combination therapy of immunotherapy plus anti-angiogenic drug for thoracic SMARCA4-deficient undifferentiated tumors in AIDS: A case report and review of the literature. Frontiers in immunology, 15, 1473578. https://doi.org/10.3389/fimmu.2024.1473578
Chicago Style (17th ed.) CitationWei, Xiaoling, Xiangju Xing, Wei Yao, Changzheng Wang, Yajie Xiao, and Xianzhi Du. "First-line Combination Therapy of Immunotherapy Plus Anti-angiogenic Drug for Thoracic SMARCA4-deficient Undifferentiated Tumors in AIDS: A Case Report and Review of the Literature." Frontiers in Immunology 15 (2025): 1473578. https://doi.org/10.3389/fimmu.2024.1473578.
MLA (9th ed.) CitationWei, Xiaoling, et al. "First-line Combination Therapy of Immunotherapy Plus Anti-angiogenic Drug for Thoracic SMARCA4-deficient Undifferentiated Tumors in AIDS: A Case Report and Review of the Literature." Frontiers in Immunology, vol. 15, 2025, p. 1473578, https://doi.org/10.3389/fimmu.2024.1473578.